I agree that this site is using cookies. You can find further informations here.
X
Akhade, Amol
6  results:
Search for persons X
?
1

Highlights from the Choosing Wisely 2022 for Resource Limit..:

Akhade, Amol ; Gyawali, Bishal ; Sullivan, Richard.
ecancermedicalscience.  16 (2022)  - p. , 2022
Link: https://doi.org/10.3332/..
 
?
2

CDK 4/6 inhibitors for adjuvant therapy in early breast can..:

Akhade, Amol ; Van Wambeke, Simon ; Gyawali, Bishal
ecancermedicalscience.  16 (2022)  - p. , 2022
Link: https://doi.org/10.3332/..
 
?
3

Pembrolizumab Weight-Based Dosing: Conviction and Lacunae i..:

Patel, Amol ; Akhade, Amol
Indian Journal of Medical and Paediatric Oncology.  43 (2022)  3 - p. 298-303 , 2022
Link: https://doi.org/10.1055/..
 
?
4

To Give or Not to Give Adjuvant Chemotherapy in Breast Canc..:

Akhade, Amol ; Mathew, Aju
South Asian Journal of Cancer.  11 (2022)  1 - p. 001-002 , 2022
Link: https://doi.org/10.1055/..
 
?
5

Pembrolizumab weight based dosing – A call for policy chang:

Patel, Amol ; Akhade, Amol ; Parikh, Purvish...
Indian Journal of Medical and Paediatric Oncology.  43 (2022)  3 - p. 306-310 , 2022
Link: https://doi.org/10.1055/..
 
?
6

To Give or Not to Give Adjuvant Chemotherapy in Breast Canc..:

Amol Akhade ; Aju Mathew
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1746411.  , 2022
Link: https://doi.org/10.1055/..
 
1-6